Medication "Symbicort": instructions for use

The medicine "Symbicort Turbuhaler" (or simply "Symbicort") instructions for use defines it as an inhalant intended for the therapy of obstructive diseases of the respiratory system.

Among the main advantages of this drug are a rapid decrease in the manifestation of bronchospasm (within the first two to three minutes), the possibility of a single use per day and at the same time a continuous control of bronchial asthma. In addition, the "Symbicort" tool, the instruction to which it confirms, increases adherence to the administration of inhaled corticosteroids.

As for the pharmacokinetics of this medication, its bronchodilator effect occurs very quickly and persists for twelve hours after taking a single dose.

The medicine "Symbicort" is issued, the instruction on which application is mandatory in the kit, in the form of powder for inhalations. Each dose contains 320 μg of micronized finely dispersed budesonide and 9 μg of formoterol fumarate dihydrate as active ingredients. In the role of an auxiliary ingredient is a substance such as lactose monohydrate.

To prescribe the inhalation means "Symbicort" the instruction for use recommends as an effective maintenance therapy for patients with bronchial asthma. In the chronic form of obstructive pulmonary disease, which occurs with periodic exacerbations, the purpose of this drug is also shown.

Use the medicine "Symbicort" instructions for use categorically prohibits people suffering from individual intolerance budesonide, inhaled lactose or formoterol. Patients younger than six years of age should also refrain from taking this inhalation drug. In addition, the list of direct contraindications includes lactose intolerance, lactase deficiency and glucose-galactose type malabsorption.

With extreme caution, this medicine is prescribed for pulmonary tuberculosis, thyrotoxicosis, diabetes mellitus and severe form of hypertension. Patients with viral, fungal or bacterial diseases of the respiratory system should also not take the drug "Symbicort". The doctors' testimonies also testify to the undesirability of its appointment to people with uncontrolled hypokalemia, severe heart failure, pheochromocytoma, ischemic disease, subaortic stenosis of idiopathic type, tachyarrhythmia or aneurysm of any site.

If we talk about the possible side effects provoked by taking the "Symbicort" medication, here first of all, one should distinguish tachycardia, headache, nausea, heart palpitations, muscle cramps, tremor, cough, sleep disturbance and dizziness. In addition, itching, hives, angioedema, exanthema, hypokalemia, hyperglycemia, angina and glaucoma can be observed. Some patients also note increased excitement, anxiety, impaired taste and a tendency to depression.